ArticleCurrent drug targets2025

GSTP1, PRDX2 and NFE2L2: Potential Markers for Primary Stage Breast Cancer.

Syeda Abiha Zehra Jaffari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.